InsidersTradesSigma
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the full record of transactions filed by Smith Julie Diana. Director active across 1 company, notably Meridian Bioscience INC. Aggregated, 5 reports have been recorded. Activity tracked since 16 September 2022. The latest transaction was filed on 6 December 2022 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
5 of 5 declarations